Cargando…
Primary midbrain germinoma relapse-free for 5 years: A case report
BACKGROUND: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. CASE DESCRIPTION: A 39-year-old man wh...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805627/ https://www.ncbi.nlm.nih.gov/pubmed/36600775 http://dx.doi.org/10.25259/SNI_703_2022 |
_version_ | 1784862369293271040 |
---|---|
author | Oshima, Akito Kimura, Toshikazu Akabane, Atsuya Inoue, Tomohiro |
author_facet | Oshima, Akito Kimura, Toshikazu Akabane, Atsuya Inoue, Tomohiro |
author_sort | Oshima, Akito |
collection | PubMed |
description | BACKGROUND: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. CASE DESCRIPTION: A 39-year-old man who had been diagnosed with midbrain germinoma by open biopsy through the occipital transtentorial approach had undergone chemoradiotherapy and achieved 5 years with no recurrence. CONCLUSION: Germinomas should be considered as a differential diagnosis for adolescents and young adult men with mesencephalic tumors, and reliable sampling followed by chemoradiotherapy must be performed. |
format | Online Article Text |
id | pubmed-9805627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Scientific Scholar |
record_format | MEDLINE/PubMed |
spelling | pubmed-98056272023-01-03 Primary midbrain germinoma relapse-free for 5 years: A case report Oshima, Akito Kimura, Toshikazu Akabane, Atsuya Inoue, Tomohiro Surg Neurol Int Case Report BACKGROUND: The biology and clinical course of intracranial germinomas differ as per their location of occurrence. Germinoma of the primary midbrain is particularly rare, and its clinical features, treatment strategies, and long-term prognosis remain uncertain. CASE DESCRIPTION: A 39-year-old man who had been diagnosed with midbrain germinoma by open biopsy through the occipital transtentorial approach had undergone chemoradiotherapy and achieved 5 years with no recurrence. CONCLUSION: Germinomas should be considered as a differential diagnosis for adolescents and young adult men with mesencephalic tumors, and reliable sampling followed by chemoradiotherapy must be performed. Scientific Scholar 2022-12-09 /pmc/articles/PMC9805627/ /pubmed/36600775 http://dx.doi.org/10.25259/SNI_703_2022 Text en Copyright: © 2022 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Oshima, Akito Kimura, Toshikazu Akabane, Atsuya Inoue, Tomohiro Primary midbrain germinoma relapse-free for 5 years: A case report |
title | Primary midbrain germinoma relapse-free for 5 years: A case report |
title_full | Primary midbrain germinoma relapse-free for 5 years: A case report |
title_fullStr | Primary midbrain germinoma relapse-free for 5 years: A case report |
title_full_unstemmed | Primary midbrain germinoma relapse-free for 5 years: A case report |
title_short | Primary midbrain germinoma relapse-free for 5 years: A case report |
title_sort | primary midbrain germinoma relapse-free for 5 years: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805627/ https://www.ncbi.nlm.nih.gov/pubmed/36600775 http://dx.doi.org/10.25259/SNI_703_2022 |
work_keys_str_mv | AT oshimaakito primarymidbraingerminomarelapsefreefor5yearsacasereport AT kimuratoshikazu primarymidbraingerminomarelapsefreefor5yearsacasereport AT akabaneatsuya primarymidbraingerminomarelapsefreefor5yearsacasereport AT inouetomohiro primarymidbraingerminomarelapsefreefor5yearsacasereport |